scispace - formally typeset
I

Irving F. Hoffman

Researcher at University of North Carolina at Chapel Hill

Publications -  288
Citations -  20382

Irving F. Hoffman is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 52, co-authored 270 publications receiving 18634 citations. Previous affiliations of Irving F. Hoffman include Kamuzu Central Hospital & FHI 360.

Papers
More filters
Journal ArticleDOI

Factors associated with a history of treatment interruption among pregnant women living with HIV in Malawi: A cross-sectional study

TL;DR: Interventions that simplify the ART clinic transfer process, facilitate partner disclosure, and provide counseling about the importance of lifelong ART beyond pregnancy and breastfeeding should be further evaluated for improving retention in ART treatment of women living with HIV in Malawi.
Journal ArticleDOI

Point-of-Care Diagnostics for Acute HIV Infection: An Important Public Health Priority

TL;DR: A test designed to concomitantly detect HIV antibodies and p24 antigen in separate reading frames at the point of care was evaluated among persons attending a sexually transmitted infection clinic and an HIV testing and counseling center in Lilongwe, Malawi, and found that the antibody portion of the test had excellent sensitivity and specificity for detecting established HIV infection.
Journal ArticleDOI

Viral Hepatitis among HIV+ Patients in Northern Vietnam

TL;DR: Compared with the general Vietnamese population, HCV was more prevalent among the authors' sample of HIV+ individuals, and future efforts for the prevention and treatment of HCV should be focused in this community.
Journal ArticleDOI

A Single Amino Acid Substitution in Elongation Factor G Can Confer Low-Level Gentamicin Resistance in Neisseria gonorrhoeae

TL;DR: It is hypothesized that the rare occurrence of fusA2 in N. gonorrhoeae clinical isolates is likely due to a fitness cost during infection, but compensatory mutations which alleviate this fitness cost could emerge and promote GenR in global strains.